Cardiovascular medicine
Influence of previous aspirin treatment and smoking on the
electrocardiographic manifestations of injury in acute myocardial
infarction
S Kennonc, K Barakata, A Sulimanc, P K MacCallumb, K Ranjadayalanc, P Wilkinsond, A D Timmisa
a Department of
Cardiology, Royal Hospitals Trust, London E1, UK, b Department of Haematology,
Royal Hospitals Trust, c Department of Cardiology, Newham Healthcare
Trust, London E13, UK, d Department
of Environmental Epidemiology, London School of Hygiene and Tropical
Medicine, Keppel Street, London WC1, UK
Correspondence to: Dr Simon Kennon, Heart and Chest Clinic, Southend Hospital, Westcliffe-on-Sea, Essex SS0 0RY, UK email: srok{at}dircon.co.uk
Accepted 23 March 2000
OBJECTIVE
To examine demographic and clinical
characteristics of patients with acute myocardial infarction in order
to identify factors affecting the electrocardiographic evolution of injury.
METHODS
Prospective cohort study of
1399 consecutive patients with a first myocardial infarction. Baseline
clinical data associated with ST elevation and Q wave development were
identified and 12 month survival was estimated.
RESULTS
Smoking had complex effects
on the evolution of injury, increasing the odds of ST elevation (odds
ratio (OR) 1.61; 95% confidence interval (CI) 1.08 to 2.36), but
reducing the odds of Q wave development (OR 0.69, 95% CI 0.49 to
0.96). The effects of previous aspirin treatment were more consistent
with reductions in the odds of ST elevation (OR 0.57, 95% CI 0.35 to
0.94) and Q wave development (OR 0.53, 95% CI 0.34 to 0.84). ST
elevation and Q wave development were both associated with an adverse
prognosis, with estimated 12 month survival rates of 80.6% (95% CI
78.2% to 83.1%) and 80.0% (95% CI 77.5% to 82.5%), respectively,
compared with 86.5% (95% CI 81.2% to 91.9%) and 89.9% (95% CI
86.2% to 93.7%) for patients without these ECG changes.
CONCLUSIONS
The thrombogenicity of
the blood may be a major determinant of infarct severity. Smoking
increases thrombogenicity and the likelihood of ST elevation, but
because coronary occlusion is relatively more thrombotic in smokers,
responses to both endogenous and exogenous thrombolysis are better,
reducing the risk of Q wave development. Previous aspirin treatment
reduces thrombogenicity, protecting against ST elevation and Q wave development.
Keywords: myocardial infarction; smoking; aspirin
© 2000 by Heart
This article has been cited by other articles:
-
Liew, R, Sulfi, S, Ranjadayalan, K, Cooper, J, Timmis, A D
(2006). Declining case fatality rates for acute myocardial infarction in South Asian and white patients in the past 15 years. Heart
92: 1030-1034
[Abstract] [Full Text] -
Timmis, A. D
(2003). Plaque stabilisation in acute coronary syndromes: clinical considerations. Heart
89: 1268-1272
[Full Text] -
Barakat, K., Kennon, S., Hitman, G. A., Aganna, E., Price, C. P., Mills, P. G., Ranjadayalan, K., North, B., Clarke, H., Timmis, A. D.
(2001). Interaction between smoking and the glycoprotein IIIa P1A2 polymorphism in Non-ST-elevation acute coronary syndromes. J Am Coll Cardiol
38: 1639-1643
[Abstract] [Full Text] -
Kennon, S., Barakat, K., Hitman, G. A., Price, C. P., Mills, P. G., Ranjadayalan, K., Cooper, J., Clark, H., Timmis, A. D.
(2001). Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non-ST-elevation acute coronary syndromes. J Am Coll Cardiol
38: 724-728
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
